On August 30, 2022 IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, reported its participation in investor conferences and events in September 2022 (Press release, Ideaya Biosciences, AUG 30, 2022, View Source [SID1234618791]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual BioPharma Conference
September 7-8, 2022

Wells Fargo Healthcare Conference
September 7-9, 2022

Morgan Stanley 20th Annual Global Healthcare Conference
September 12-14, 2022
Monday, September 12 at 4:15pm ET
Fireside chat with Yujiro Hata, Chief Executive Officer, IDEAYA Biosciences, hosted by Ashwin Pai, M.D. Managing Director

Baird 20th 2022 Global Healthcare Conference
September 13-14, 2022
Wednesday, September 14 at 9:05am ET
Corporate Presentation by Paul Stone, Chief Financial Officer, IDEAYA Biosciences

Oppenheimer’s Oncology Summit / University of Texas MD Anderson Cancer Center
September 21, 2022

Cantor Oncology, Hematology & HemOnc Conference
September 28, 2022
Wednesday, September 28
Panel: "Novel Targets in Oncology: Risk vs. Reward", with participation by Mike White, Chief Scientific Officer, IDEAYA Biosciences

A live audio webcast of the event will be available, as permitted by conference host, at the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at View Source A replay of available webcasts will be accessible for 30 days following the live event.